Gain Clarity in Complexity: Transforming Neurodegeneration Research with Biomarker Precision

September 17, 2025 | Virtual event: 7:00 AM (PST), 10:00 AM (EST), 4:00 PM (CET)

Introducing the new Olink Target 48 Neurodegeneration panel

Neurodegenerative diseases present some of the greatest challenges in medicine due to their complexity, heterogeneity, and the limited availability of reliable biomarkers and treatments. Join us for the launch of our new, innovative Olink biomarker solution for neurodegeneration research—designed to empower scientists across academia and industry with greater precision and confidence.

This powerful new panel enables simultaneous, absolute quantification of both established and emerging key neurodegenerative biomarkers, unlocking new translational insights into disease mechanisms previously beyond reach.

Whether you're investigating disease pathways, developing interventions, or evaluating treatment response, this webinar will introduce an innovative tool to drive your work forward with greater clarity and confidence.

Learn how this comprehensive tool can support you to:

  • Confidently track neurodegenerative biomarkers from plasma or CSF in a single scalable assay
  • Dive deeper into disease mechanisms with carefully curated content, including emerging and established biomarkers
  • Generate robust, reproducible data across studies, sites, and timepoints enabling longitudinal and cross-cohort comparisons

Be among the first to see how this innovation can power your neurodegeneration research!

For Research Use Only. Not for use in diagnostic procedures.